Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 13, 2020 - Issue 4
Submit an article Journal homepage
494
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Risk of acute pancreatitis with incretin-based therapy: a systematic review and updated meta-analysis of cardiovascular outcomes trials

Awadhesh Kumar Singha Department of Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, IndiaCorrespondence[email protected]
View further author information
,
Kalyan Kumar Gangopadhyayb Department of Endocrinology, Fortis & Peerless Hospital, Kolkata, IndiaView further author information
&
Ritu Singhc Department of Gynecology & Obstetrics, G. D Hospital & Diabetes Institute, Kolkata, IndiaView further author information
Pages 461-468 | Received 15 Nov 2019, Accepted 25 Feb 2020, Published online: 04 Mar 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Debbie Hinnen, Davida Kruger & Melissa Magwire. (2023) Type 2 diabetes and cardiovascular disease: risk reduction and early intervention. Postgraduate Medicine 135:1, pages 2-12.
Read now

Articles from other publishers (9)

Chantal Mathieu & Iraj Ahmadzai. (2023) Incretins beyond type 2 diabetes. Diabetologia.
Crossref
Mark O. Goodarzi & Maxim S. Petrov. (2023) Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management. Drugs 83:12, pages 1077-1090.
Crossref
Ana Dugic, Hannes Hagström, Ingrid Dahlman, Wiktor Rutkowski, Diana Daou, Paula Kulinski, J.‐Matthias Löhr & Miroslav Vujasinovic. (2022) Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes. United European Gastroenterology Journal 11:1, pages 79-91.
Crossref
Fan Yang, Youzi Dong, Baohua Li, Bobiao Ning & Quanlin Zhao. (2022) Pancreatic safety of DPP-4 inhibitors in type 2 diabetes millitus. Medicine 101:17, pages e29154.
Crossref
André J. Scheen. (2021) Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes. Diabetes & Metabolism 47:6, pages 101275.
Crossref
Phil A. Hart, Dana K. Andersen, Maxim S. Petrov & Mark O. Goodarzi. (2021) Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus. Current Opinion in Gastroenterology 37:5, pages 520-525.
Crossref
Phil A Hart, David Bradley, Darwin L Conwell, Kathleen Dungan, Somashekar G Krishna, Kathleen Wyne, Melena D Bellin, Dhiraj Yadav, Dana K Andersen, Jose Serrano & Georgios I Papachristou. (2021) Diabetes following acute pancreatitis. The Lancet Gastroenterology & Hepatology 6:8, pages 668-675.
Crossref
. (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine 385:1, pages e4.
Crossref
Ju Hee Lee. (2021) Dipeptidyl Peptidase 4 Inhibitor, an Update. The Journal of Korean Diabetes 22:2, pages 91-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.